These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3567077)

  • 1. Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine.
    Battle AM; Stella AM; De Kaminsky AR; Kaminsky C; Mariano HG
    Br J Dermatol; 1987 Mar; 116(3):407-15. PubMed ID: 3567077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.
    Ashton RE; Hawk JL; Magnus IA
    Br J Dermatol; 1984 Nov; 111(5):609-13. PubMed ID: 6498093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda and pregnancy.
    Goerz G; Hammer G
    Dermatologica; 1983 Jun; 166(6):316-8. PubMed ID: 6884554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum and urinary porphyrin levels in porphyria cutanea tarda.
    Kalb RE; Grossman ME; Poh-Fitzpatrick MB
    Arch Dermatol; 1985 Oct; 121(10):1289-91. PubMed ID: 4037823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of S-adenosyl-L-methionine in hepatic uroporphyria. Evaluation in an experimental model.
    Cantoni L; Budillon G; Cuomo R; Rodinò S; Le Grazie C; Di Padova C; Rizzardini M
    Scand J Gastroenterol; 1990 Oct; 25(10):1034-40. PubMed ID: 2263875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria Cutanea tarda in Missouri.
    Anderson PC
    Mo Med; 1981 Jun; 78(6):299-302. PubMed ID: 7254176
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E
    Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)].
    Goerz G; Krieg T; Eichenauer MG
    Arch Dermatol Res (1975); 1976 Apr; 255(2):169-76. PubMed ID: 1275551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine in the treatment of porphyria cutanea tarda.
    Tsega E; Besrat A; Damtew B; Seyoum E; Landells JW
    Trans R Soc Trop Med Hyg; 1981; 75(3):401-4. PubMed ID: 7324107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects.
    Saltzer EI; Redeker AG; Wilson JW
    Arch Dermatol; 1968 Nov; 98(5):496-8. PubMed ID: 5693347
    [No Abstract]   [Full Text] [Related]  

  • 15. [Porphyria cutanea tarda: possible treatment and its results (author's transl)].
    Goerz G; Krieg T
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1329-33. PubMed ID: 308001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of porphyrin-excretion in female estrogen-induced porphyria cutanea tarda.
    Enríquez de Salamanca R; Mingo D; Chinarro S; Muñoz JJ; Perpiñá J
    Arch Dermatol Res; 1982; 274(1-2):179-84. PubMed ID: 7165364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodialysis-related porphyria cutanea tarda and treatment by recombinant human erythropoietin.
    Yaqoob M; Smyth J; Ahmad R; McClelland P; Fahal I; Kumar KA; Yu R; Verbov J
    Nephron; 1992; 60(4):428-31. PubMed ID: 1584318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of porphyria cutanea tarda after treatment with cyclophosphamide.
    Manzione NC; Wolkoff AW; Sassa S
    Gastroenterology; 1988 Oct; 95(4):1119-22. PubMed ID: 3410226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.